SMTI Sanara MedTech Inc

Price (delayed)

$22.11

Market cap

$202.62M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.88

Enterprise value

$237.39M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 28

With a focus on improving patient outcomes through evidence-based healing solutions and services, Sanara MedTech Inc. markets and distributes wound and skin care products and is seeking to offer wound ...

Highlights
Sanara MedTech's gross profit has increased by 20% YoY and by 4.5% QoQ
The company's revenue rose by 17% YoY and by 4.3% QoQ
Sanara MedTech's net income has shrunk by 194% YoY but it has increased by 11% QoQ
SMTI's EPS has dropped by 190% year-on-year but it is up by 11% since the previous quarter
Sanara MedTech's debt has increased by 8% YoY

Key stats

What are the main financial stats of SMTI

SMTI stock price

How has the Sanara MedTech stock price performed over time
Intraday
5.44%
1 week
-7.06%
1 month
16.43%
1 year
-24.54%
YTD
-5.31%
QTD
28.7%

Financial performance

How have Sanara MedTech's revenue and profit performed over time
Revenue
$107.51M
Gross profit
$99.9M
Operating income
$6.61M
Net income
-$33.58M
Gross margin
92.9%
Net margin
-31.2%
Sanara MedTech's net income has shrunk by 194% YoY but it has increased by 11% QoQ
Sanara MedTech's net margin has shrunk by 150% YoY but it has increased by 14% QoQ
Sanara MedTech's gross profit has increased by 20% YoY and by 4.5% QoQ
The company's revenue rose by 17% YoY and by 4.3% QoQ

Price vs fundamentals

How does SMTI's price correlate with its fundamentals

Growth

What is Sanara MedTech's growth rate over time

Valuation

What is Sanara MedTech stock price valuation
P/E
N/A
P/B
28.84
P/S
1.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.21
SMTI's EPS has dropped by 190% year-on-year but it is up by 11% since the previous quarter
The price to book (P/B) is 142% higher than the 5-year quarterly average of 11.3
SMTI's equity has dropped by 81% year-on-year but it is up by 18% since the previous quarter
The P/S is 69% lower than the 5-year quarterly average of 5.5 and 19% lower than the last 4 quarters average of 2.1
The company's revenue rose by 17% YoY and by 4.3% QoQ

Efficiency

How efficient is Sanara MedTech business performance
Sanara MedTech's return on invested capital has shrunk by 168% YoY but it has increased by 17% QoQ
The company's return on equity fell by 38% QoQ
SMTI's return on sales is up by 18% since the previous quarter
The company's return on assets rose by 2.9% QoQ

Dividends

What is SMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SMTI.

Financial health

How did Sanara MedTech financials performed over time
The company's total assets is 11% higher than its total liabilities
SMTI's quick ratio is up by 30% QoQ but it is down by 19% YoY
The company's total assets fell by 28% YoY and by 5% QoQ
SMTI's equity has dropped by 81% year-on-year but it is up by 18% since the previous quarter
SMTI's debt to equity is down by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.